Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Capital Lp Commodore currently holds 4,400,000 shares of Satsuma Pharmaceuticals, Inc. (STSA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Lp Commodore has been a net buyer of STSA stock. They have purchased $27.6M and sold $21.2M worth of shares.
Capital Lp Commodore's most recent insider trade was on Jan 10, 2024, when they sold 1,050,000 shares at $18.00 per share.
Capital Lp Commodore serves as Executive at Satsuma Pharmaceuticals, Inc. (STSA). They have executed 26 insider transactions totaling $48.8M over their tenure at the company.
Capital Lp Commodore holds the position of Executive at Satsuma Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Capital Lp Commodore has shown a buying trading pattern, with $27.6M in total purchases and $21.2M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Capital Lp Commodore was on Jan 10, 2024, when they sold $18.9M worth of VERA shares. This transaction involved 1,050,000 shares at $18.00 per share.
Capital Lp Commodore currently owns 4,400,000 shares of Satsuma Pharmaceuticals, Inc. (STSA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Capital Lp Commodore's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Capital Lp Commodore has 26 Form 4 filings on record as an insider at Satsuma Pharmaceuticals, Inc..
Set alerts for Capital Lp Commodore and 40,000+ other insiders.